Researchers have successfully modified probiotic bacteria to seek out and destroy cancer cells. This innovative approach harnesses the natural properties of probiotics, which are known for their health benefits in the gut, and repurposes them as targeted cancer therapies. The modified bacteria are designed to identify tumor environments and release therapeutic agents directly at the site of cancerous growths, potentially enhancing the effectiveness of treatment while minimizing side effects.
The study demonstrates that these engineered probiotics can not only locate tumors but also activate immune responses against them. This dual action could lead to more effective cancer treatments that work in conjunction with existing therapies, such as chemotherapy and immunotherapy. The research team is optimistic about the future applications of this technology, which could lead to new strategies for cancer management.
Source: news.google.com